Corticotropin-Releasing Factor receptor 1 (CRF1) antagonism in patients with alcohol use disorder and high anxiety levels: effect on neural response during Trier Social Stress Test video feedback
In preclinical models of alcohol use disorder, the corticotropin-releasing factor (CRF) receptor is upregulated, particularly in the extended amygdala. This upregulation is thought to play a role in stress-induced relapse to drinking by a mechanism that is independent of the hypothalamic-pituitary-a...
Saved in:
Published in | Neuropsychopharmacology (New York, N.Y.) Vol. 48; no. 5; pp. 816 - 820 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Nature Publishing Group
01.04.2023
Springer International Publishing |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In preclinical models of alcohol use disorder, the corticotropin-releasing factor (CRF) receptor is upregulated, particularly in the extended amygdala. This upregulation is thought to play a role in stress-induced relapse to drinking by a mechanism that is independent of the hypothalamic-pituitary-adrenal axis. As part of a double-blind, placebo-controlled clinical study with pexacerfont, a selective, orally available, and brain-penetrant CRF1 receptor antagonist which has anti-anxiety effects in preclinical studies, we examined the effect of pexacerfont on the neural response to a social stress task adapted to fMRI. Subjects were 39 individuals (4 women) with high trait anxiety and moderate to severe alcohol use disorder randomized to receive pexacerfont or placebo. The task involved feedback of videoclips of an individual performing the Trier Social Stress Test. Pexacerfont had no effect on the neural response to self-observation under stress. The neural response to viewing oneself under stress vs an unknown other under stress activated prefrontal brain regions including insula, inferior frontal gyrus as well as medial, superior frontal gyri. These regions of activation overlap with those found in studies using similar paradigms. Potential applications of this task to probe neurocircuitry that is disrupted in addiction is discussed. |
---|---|
AbstractList | In preclinical models of alcohol use disorder, the corticotropin-releasing factor (CRF) receptor is upregulated, particularly in the extended amygdala. This upregulation is thought to play a role in stress-induced relapse to drinking by a mechanism that is independent of the hypothalamic-pituitary-adrenal axis. As part of a double-blind, placebo-controlled clinical study with pexacerfont, a selective, orally available, and brain-penetrant CRF1 receptor antagonist which has anti-anxiety effects in preclinical studies, we examined the effect of pexacerfont on the neural response to a social stress task adapted to fMRI. Subjects were 39 individuals (4 women) with high trait anxiety and moderate to severe alcohol use disorder randomized to receive pexacerfont or placebo. The task involved feedback of videoclips of an individual performing the Trier Social Stress Test. Pexacerfont had no effect on the neural response to self-observation under stress. The neural response to viewing oneself under stress vs an unknown other under stress activated prefrontal brain regions including insula, inferior frontal gyrus as well as medial, superior frontal gyri. These regions of activation overlap with those found in studies using similar paradigms. Potential applications of this task to probe neurocircuitry that is disrupted in addiction is discussed. In preclinical models of alcohol use disorder, the corticotropin-releasing factor (CRF) receptor is upregulated, particularly in the extended amygdala. This upregulation is thought to play a role in stress-induced relapse to drinking by a mechanism that is independent of the hypothalamic-pituitary-adrenal axis. As part of a double-blind, placebo-controlled clinical study with pexacerfont, a selective, orally available, and brain-penetrant CRF1 receptor antagonist which has anti-anxiety effects in preclinical studies, we examined the effect of pexacerfont on the neural response to a social stress task adapted to fMRI. Subjects were 39 individuals (4 women) with high trait anxiety and moderate to severe alcohol use disorder randomized to receive pexacerfont or placebo. The task involved feedback of videoclips of an individual performing the Trier Social Stress Test. Pexacerfont had no effect on the neural response to self-observation under stress. The neural response to viewing oneself under stress vs an unknown other under stress activated prefrontal brain regions including insula, inferior frontal gyrus as well as medial, superior frontal gyri. These regions of activation overlap with those found in studies using similar paradigms. Potential applications of this task to probe neurocircuitry that is disrupted in addiction is discussed.In preclinical models of alcohol use disorder, the corticotropin-releasing factor (CRF) receptor is upregulated, particularly in the extended amygdala. This upregulation is thought to play a role in stress-induced relapse to drinking by a mechanism that is independent of the hypothalamic-pituitary-adrenal axis. As part of a double-blind, placebo-controlled clinical study with pexacerfont, a selective, orally available, and brain-penetrant CRF1 receptor antagonist which has anti-anxiety effects in preclinical studies, we examined the effect of pexacerfont on the neural response to a social stress task adapted to fMRI. Subjects were 39 individuals (4 women) with high trait anxiety and moderate to severe alcohol use disorder randomized to receive pexacerfont or placebo. The task involved feedback of videoclips of an individual performing the Trier Social Stress Test. Pexacerfont had no effect on the neural response to self-observation under stress. The neural response to viewing oneself under stress vs an unknown other under stress activated prefrontal brain regions including insula, inferior frontal gyrus as well as medial, superior frontal gyri. These regions of activation overlap with those found in studies using similar paradigms. Potential applications of this task to probe neurocircuitry that is disrupted in addiction is discussed. |
Author | Rio, Daniel Momenan, Reza Heilig, Markus Lee, Mary R. George, David T. Kwako, Laura |
Author_xml | – sequence: 1 givenname: Mary R. surname: Lee fullname: Lee, Mary R. – sequence: 2 givenname: Daniel surname: Rio fullname: Rio, Daniel – sequence: 3 givenname: Laura orcidid: 0000-0003-1899-2098 surname: Kwako fullname: Kwako, Laura – sequence: 4 givenname: David T. surname: George fullname: George, David T. – sequence: 5 givenname: Markus surname: Heilig fullname: Heilig, Markus – sequence: 6 givenname: Reza orcidid: 0000-0002-7624-9676 surname: Momenan fullname: Momenan, Reza |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36564531$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-191201$$DView record from Swedish Publication Index |
BookMark | eNp9ksFu1DAQhi1URLeFF-CALHEph4AdJ07CBVULC5UqIbUL6s1ynMmui9cOtrOlfT1eDKfbItoDJ1ua7x__M_4P0J51FhB6SclbSlj9LhSU1TwjeZ4RWuY0u3mCZrQqSMZZcbGHZqRuWEYZu9hHByFckkRVvH6G9hkveVEyOkO_585HrVz0btA2OwMDMmi7wgupovPYg4JhulB8ND9b0DdY2ihXzuqwwdriQUYNNgZ8peMaS6Pc2hk8BsCdDs534JOgw2u9SlX7S0O8xga2YMJ7DH0PKmJnsYXRS5MeC4Ozk3b0k4el10l_7pROxfOYygEvIUS81R043AN0rVQ_nqOnvTQBXtydh-jb4tNy_iU7_fr5ZH58mqmCNzFroOkKIJWUvAWQPauroqtJRVopSUkZqXKiZFco1lBV9FVXKQY1LxjrStq0LTtE2a5vuIJhbMXg9Ub6a-GkFh_192Ph_EoYPQra0JzQxH_Y8QneQKfSntKUD2QPK1avxcptBSWE87ypUoejuw7e_RzT5GKjgwJjpAU3BpFXZU0pb_j02OtH6KUbvU37SFTDcl6nUCTq1b-W_nq5D0QC6h2gvAvBQy-UjumP3eRQm2RNTNkTu-yJlD1xmz1xk6T5I-l99_-I_gDrYOEg |
CitedBy_id | crossref_primary_10_1038_s41386_023_01539_x crossref_primary_10_1038_s41386_023_01693_2 |
Cites_doi | 10.1002/da.20695 10.1016/j.neuron.2016.11.034 10.1007/s002130000411 10.1207/s15327752jpa6801_7 10.1016/j.neuron.2018.03.048 10.1016/j.neuroimage.2014.06.027 10.3389/fpsyg.2018.01825 10.1037/1040-3590.19.1.119 10.1037/bne0000305 10.1006/cbmr.1996.0014 10.1111/j.1530-0277.2011.01452.x 10.1016/j.neubiorev.2015.12.003 10.1037/t05183-000 10.1016/j.neuropsychologia.2013.11.022 10.1016/S0145-2134(02)00541-0 10.1159/000119004 10.1176/appi.books.9780890425596 10.1038/s41598-018-32828-x 10.1016/j.biopsych.2013.02.026 10.1016/j.pscychresns.2018.12.016 10.1196/annals.1314.032 10.1002/hbm.20168 10.1093/alcalc/agab062 10.1002/jts.2490060405 10.3389/fpsyt.2022.893833 10.1007/s00213-007-0905-x 10.1176/appi.ajp.2008.07071199 10.1016/j.tins.2007.06.006 10.1523/JNEUROSCI.4985-06.2007 10.1038/npp.2014.306 10.1111/j.1530-0277.1995.tb01554.x 10.1016/j.drugalcdep.2012.12.017 10.1016/0006-8993(93)91352-S 10.1037/t06496-000 10.1016/j.pscychresns.2018.12.017 |
ContentType | Journal Article |
Copyright | 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022 |
Copyright_xml | – notice: 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. – notice: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022. – notice: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 88G 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM ADTPV AOWAS DG8 |
DOI | 10.1038/s41386-022-01521-z |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Psychology Database Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SwePub Articles SWEPUB Linköpings universitet |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest One Psychology MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1740-634X |
EndPage | 820 |
ExternalDocumentID | oai_DiVA_org_liu_191201 PMC10066297 36564531 10_1038_s41386_022_01521_z |
Genre | Randomized Controlled Trial Journal Article Research Support, N.I.H., Intramural |
GrantInformation_xml | – fundername: ; |
GroupedDBID | --- -DZ 0R~ 29N 2WC 36B 39C 4.4 406 5RE 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAYXX AAYZH ABAKF ABBRH ABDBE ABFSG ABIVO ABJNI ABLJU ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACMFV ACMJI ACPRK ACSTC ACZOJ ADBBV ADFRT AEFQL AEJRE AEMSY AENEX AESKC AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AOIJS ASPBG ATHPR AVWKF AYFIA AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BPHCQ BVXVI CCPQU CITATION CS3 DIK DNIVK DPUIP DWQXO E3Z EBLON EBS EE. F5P FDB FDQFY FIGPU FYUFA GNUQQ GX1 HCIFZ HMCUK HYE HZ~ IWAJR JSO JZLTJ KQ8 LGEZI LOTEE M1P M2M M7P NADUK NQJWS NXXTH O9- OK1 P2P P6G PHGZM PHGZT PQQKQ PROAC PSQYO PSYQQ Q2X RNT RNTTT ROL RPM SNX SNYQT SOJ SRMVM SWTZT TAOOD TR2 UKHRP W2D ZGI --K -Q- 1B1 53G 5VS AAEDT AALRI AAQFI AAQXK AAXUO ABMAC ABRTQ ABWVN ACIUM ACRPL ACRQY ACVFH ADCNI ADMUD ADNMO AEUPX AFPUW AGQPQ CAG CGR COF CUY CVF ECM EIF EIOEI EJD EMB EMOBN FEDTE FERAY FGOYB FIZPM FSGXE HVGLF IHE M41 MK0 NPM NQ- PJZUB PPXIY PQGLB R2- RIG RNS RPZ SEW SOHCF SSZ SV3 TBHMF TDRGL ZKB 3V. 7TK 7XB 8FE 8FH 8FK K9. LK8 PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM ADTPV AOWAS DG8 |
ID | FETCH-LOGICAL-c469t-9e9d4e07aa6beeaf3874d8070baa05130720cad4c391c4f7d7c3e86433d519bb3 |
IEDL.DBID | 7X7 |
ISSN | 0893-133X 1740-634X |
IngestDate | Thu Aug 21 06:24:38 EDT 2025 Thu Aug 21 18:35:00 EDT 2025 Thu Jul 10 23:33:31 EDT 2025 Fri Jul 25 08:56:21 EDT 2025 Mon Jul 21 06:02:46 EDT 2025 Tue Jul 01 01:05:45 EDT 2025 Thu Apr 24 22:58:55 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c469t-9e9d4e07aa6beeaf3874d8070baa05130720cad4c391c4f7d7c3e86433d519bb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
ORCID | 0000-0003-1899-2098 0000-0002-7624-9676 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/10066297 |
PMID | 36564531 |
PQID | 2793268634 |
PQPubID | 33935 |
PageCount | 5 |
ParticipantIDs | swepub_primary_oai_DiVA_org_liu_191201 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10066297 proquest_miscellaneous_2758116961 proquest_journals_2793268634 pubmed_primary_36564531 crossref_citationtrail_10_1038_s41386_022_01521_z crossref_primary_10_1038_s41386_022_01521_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-04-01 |
PublicationDateYYYYMMDD | 2023-04-01 |
PublicationDate_xml | – month: 04 year: 2023 text: 2023-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: New York – name: Cham |
PublicationTitle | Neuropsychopharmacology (New York, N.Y.) |
PublicationTitleAlternate | Neuropsychopharmacology |
PublicationYear | 2023 |
Publisher | Nature Publishing Group Springer International Publishing |
Publisher_xml | – name: Nature Publishing Group – name: Springer International Publishing |
References | AD Lê (1521_CR9) 2000; 150 PT Costa Jr (1521_CR24) 1997; 68 C Galandra (1521_CR32) 2018; 8 S Rassnick (1521_CR7) 1993; 605 AI Alterman (1521_CR22) 2007; 19 1521_CR14 G Chen (1521_CR27) 2014; 99 1521_CR15 V Coric (1521_CR6) 2010; 27 LE Kwako (1521_CR11) 2015; 40 C Kirschbaum (1521_CR12) 1993; 28 EB Foa (1521_CR28) 1993; 6 TC Durazzo (1521_CR33) 2011; 35 EV Sullivan (1521_CR35) 2013; 74 RW Cox (1521_CR26) 1996; 29 PW Marinelli (1521_CR10) 2007; 195 CB Padula (1521_CR37) 2022; 13 DP Bernstein (1521_CR23) 2003; 27 CA Sanford (1521_CR2) 2017; 93 SM Platek (1521_CR29) 2006; 27 TJ Butcher (1521_CR36) 2021; 57 F Benuzzi (1521_CR30) 2018; 9 1521_CR25 EP Zorrilla (1521_CR4) 2013; 128 LA Brown (1521_CR18) 2019; 284 1521_CR21 TR Orem (1521_CR19) 2019; 133 1521_CR1 DR Gehlert (1521_CR8) 2007; 27 MJ Bohn (1521_CR16) 1995; 19 C Hu (1521_CR20) 2016; 61 B Binneman (1521_CR5) 2008; 165 MR Lee (1521_CR17) 2014; 53 R Sinha (1521_CR13) 2004; 1032 M Heilig (1521_CR3) 2007; 30 A Zilverstand (1521_CR31) 2018; 98 ME Halcomb (1521_CR34) 2019; 284 36725866 - Neuropsychopharmacology. 2023 Apr;48(5):711-712 |
References_xml | – volume: 27 start-page: 417 year: 2010 ident: 1521_CR6 publication-title: Depress Anxiety doi: 10.1002/da.20695 – ident: 1521_CR25 – volume: 93 start-page: 164 year: 2017 ident: 1521_CR2 publication-title: Neuron doi: 10.1016/j.neuron.2016.11.034 – volume: 150 start-page: 317 year: 2000 ident: 1521_CR9 publication-title: Psychopharmacology doi: 10.1007/s002130000411 – volume: 68 start-page: 86 year: 1997 ident: 1521_CR24 publication-title: J Pers Assess doi: 10.1207/s15327752jpa6801_7 – volume: 98 start-page: 886 year: 2018 ident: 1521_CR31 publication-title: Neuron doi: 10.1016/j.neuron.2018.03.048 – volume: 99 start-page: 571 year: 2014 ident: 1521_CR27 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2014.06.027 – volume: 9 start-page: 1825 year: 2018 ident: 1521_CR30 publication-title: Front Psychol doi: 10.3389/fpsyg.2018.01825 – volume: 19 start-page: 119 year: 2007 ident: 1521_CR22 publication-title: Psychol Assess doi: 10.1037/1040-3590.19.1.119 – volume: 133 start-page: 203 year: 2019 ident: 1521_CR19 publication-title: Behav Neurosci doi: 10.1037/bne0000305 – volume: 29 start-page: 162 year: 1996 ident: 1521_CR26 publication-title: Comput Biomed Res doi: 10.1006/cbmr.1996.0014 – volume: 35 start-page: 1187 year: 2011 ident: 1521_CR33 publication-title: Alcohol Clin Exp Res doi: 10.1111/j.1530-0277.2011.01452.x – volume: 61 start-page: 197 year: 2016 ident: 1521_CR20 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2015.12.003 – ident: 1521_CR15 doi: 10.1037/t05183-000 – volume: 53 start-page: 257 year: 2014 ident: 1521_CR17 publication-title: Neuropsychologia doi: 10.1016/j.neuropsychologia.2013.11.022 – volume: 27 start-page: 169 year: 2003 ident: 1521_CR23 publication-title: Child Abus Negl doi: 10.1016/S0145-2134(02)00541-0 – volume: 28 start-page: 76 year: 1993 ident: 1521_CR12 publication-title: Neuropsychobiology doi: 10.1159/000119004 – ident: 1521_CR1 doi: 10.1176/appi.books.9780890425596 – volume: 8 year: 2018 ident: 1521_CR32 publication-title: Sci Rep doi: 10.1038/s41598-018-32828-x – volume: 74 start-page: 547 year: 2013 ident: 1521_CR35 publication-title: Biol psychiatry doi: 10.1016/j.biopsych.2013.02.026 – volume: 284 start-page: 21 year: 2019 ident: 1521_CR34 publication-title: Psychiatry Res: Neuroimaging doi: 10.1016/j.pscychresns.2018.12.016 – volume: 1032 start-page: 254 year: 2004 ident: 1521_CR13 publication-title: Ann NY Acad Sci doi: 10.1196/annals.1314.032 – ident: 1521_CR14 – volume: 27 start-page: 91 year: 2006 ident: 1521_CR29 publication-title: Hum Brain Mapp doi: 10.1002/hbm.20168 – volume: 57 start-page: 445 year: 2021 ident: 1521_CR36 publication-title: Alcohol Alcohol doi: 10.1093/alcalc/agab062 – volume: 6 start-page: 459 year: 1993 ident: 1521_CR28 publication-title: J Trauma Stress doi: 10.1002/jts.2490060405 – volume: 13 start-page: 893833 year: 2022 ident: 1521_CR37 publication-title: Front Psychiatry doi: 10.3389/fpsyt.2022.893833 – volume: 195 start-page: 345 year: 2007 ident: 1521_CR10 publication-title: Psychopharmacology doi: 10.1007/s00213-007-0905-x – volume: 165 start-page: 617 year: 2008 ident: 1521_CR5 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2008.07071199 – volume: 30 start-page: 399 year: 2007 ident: 1521_CR3 publication-title: Trends Neurosci doi: 10.1016/j.tins.2007.06.006 – volume: 27 start-page: 2718 year: 2007 ident: 1521_CR8 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4985-06.2007 – volume: 40 start-page: 1053 year: 2015 ident: 1521_CR11 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2014.306 – volume: 19 start-page: 600 year: 1995 ident: 1521_CR16 publication-title: Alcohol: Clin Exp Res doi: 10.1111/j.1530-0277.1995.tb01554.x – volume: 128 start-page: 175 year: 2013 ident: 1521_CR4 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2012.12.017 – volume: 605 start-page: 25 year: 1993 ident: 1521_CR7 publication-title: Brain Res doi: 10.1016/0006-8993(93)91352-S – ident: 1521_CR21 doi: 10.1037/t06496-000 – volume: 284 start-page: 13 year: 2019 ident: 1521_CR18 publication-title: Psychiatry Res: Neuroimaging doi: 10.1016/j.pscychresns.2018.12.017 – reference: 36725866 - Neuropsychopharmacology. 2023 Apr;48(5):711-712 |
SSID | ssj0015768 |
Score | 2.4240277 |
Snippet | In preclinical models of alcohol use disorder, the corticotropin-releasing factor (CRF) receptor is upregulated, particularly in the extended amygdala. This... |
SourceID | swepub pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 816 |
SubjectTerms | Addictions Alcohol use Alcoholism - diagnostic imaging Alcoholism - drug therapy Amygdala Anxiety Brain mapping Clinical trials Corticotropin-releasing hormone Corticotropin-Releasing Hormone - metabolism Drinking behavior Feedback Female Frontal gyrus Functional magnetic resonance imaging Humans Hypothalamic-pituitary-adrenal axis Hypothalamo-Hypophyseal System - metabolism Hypothalamus Male Pituitary Pituitary-Adrenal System - metabolism Placebos Psychological Tests Receptors, Corticotropin-Releasing Hormone Social interactions |
Title | Corticotropin-Releasing Factor receptor 1 (CRF1) antagonism in patients with alcohol use disorder and high anxiety levels: effect on neural response during Trier Social Stress Test video feedback |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36564531 https://www.proquest.com/docview/2793268634 https://www.proquest.com/docview/2758116961 https://pubmed.ncbi.nlm.nih.gov/PMC10066297 https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-191201 |
Volume | 48 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1tb9MwELZgkxBfEHS8FMZ0SKgCsWh1nOaFL6h0qwaIaSod6jfLSZxR0SWlaSW6v8cf4852M1WT9i2R7VaJL3fPne-eY-wtej052nXlhSkX6KDEqZdovE0L1VMJYliuTYLsWXh6EXyd9CYu4Fa7tMqNTjSKOq8yipEf-REhjTgUwaf5H4-6RtHpqmuhcZ_tEnUZSXU0aRwuTljaoMhEeOiLTVzRTFfERzUq75jSbykxAU2Yd71tmG6hzdtJk1vUosYcDR-zRw5HQt9u_BN2T5ctttcv0Ye-WkMHTGanCZm32IPv7gC9xTrnlqp6fQjjm8qr-tCsaEis13vs36Cin66WC6qo8kZonRSFFWBoGvQAKko9pwsO7wajIX8PuEXqEjVEfQXTEhxfaw0U6AVlG_HCqtaQO75PXJADsSXjxV_KHIUZJTDVH8HmmEBVArFt4lMubCIvrjVFlTCmNntgK4vhh6l2gTG-RqCiwgoKtMipyn4_ZRfDk_Hg1HMNH7wMvfQlSkmSB7obKRWmWqtCxFGQx6iUUqVQeaA68ruZyoNMJDwLiiiPMqFjxFQiRyCapuIZ2ymrUr9g4HeTAsWFhCYIsjykWFfAiyjTiDF9nrYZ3-y2zBwbOjXlmElzKi9iaSVEooRIIyHyus0-NGvmlgvkztn7GyGSTi_U8kaK2-xNM4xfNB3TqFJXK5rTizkPk5C32XMrc83fiZDYfwSOxFvS2EwgtvDtkXL6y7CGc0P2n0Rt1rGCu7XmePqzL6vFpZxNVxJ9eMSFL-9-gFfsoY-Az2Yx7bOd5WKlXyNAW6YH5is8YLufT87OR3h3_OXbf4fBPw8 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEF2VIgEvCFIugQKDBBGIWs16HV-QEIpSopZehEqK8ras7XWJSO0QJ4L0o_gJfoyZXcdVVKlvfXPkXSeOj2fO7J6ZYewVRj0p-nXl-DEXGKCEsRNp_BhnqqMi5LBcG4Hskb974n0edoZr7O8yF4ZklUubaAx1WiS0Rr7tBsQ0Ql94Hye_HOoaRburyxYaFhb7evEbQ7byw94OPt_Xrtv_NOjtOlVXASfBUHCGPyVKPd0OlPJjrVUmwsBLQ0R-rBQiFDHvthOVeomIeOJlQRokQofouEWKbCeOBV73BruJjrdNwV4wrAM8TtzdsNZIOBj7DasknbYIt0t0FiHJfUkIgS7TOV91hJfY7WWR5kopU-P--vfY3Yq3QtcC7T5b03mDbXRzjNnPFtACoyQ1S_QNduuw2rBvsNYXWxp7sQWDi0yvcsvMqItmLzbYv15Bly5mU8rgco7RGypaxoC-aQgEaJj1hA44vOkd9_lbQEioU7RI5RmMcqjqw5ZAC8ugbONfmJca0qq-KE5Igaoz48EfUqrCmART5XuwmhYocqDqnniXUyscxrkmiRMG1NYPbCYzfDXZNTDAvxEoibGADBlArJKfD9jJtUDhIVvPi1w_ZuC2owzhSSD1vCT1aW3N41mQaOS0Lo-bjC-ftkyq6uvUBGQsjQpAhNIiRCJCpEGIPG-yd_Wcia09cuXozSWIZGWHSnnx1jTZy_o0WhDaFlK5LuY0phNy7kc-b7JHFnP11wmfqg0JPBOuoLEeQNXJV8_kox-mSjk3zQWioMlaFrgrc3ZG37qymJ7K8WguecSRhz65-gZesNu7g8MDebB3tP-U3XGRbFoF1SZbn03n-hmSw1n83LyRwL5ftwn4DweQedM |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9NAEF2VVKq4IEj5CBQYJIhA1ErWdvyBhFBIGrUUoqikKLdlba9LRGqHOBGkP40rf4yZXSdVVKm33hzZ68Tx25k3u29mGHuJUU-Cfl1aXsQdDFCCyAoVfoxS2ZIhcliutEC27x2eup9GrdEW-7vKhSFZ5comakOd5DGtkTdsn5hG4DluIy1lEYNu78P0l0UdpGinddVOw0DkWC1_Y_hWvD_q4rt-Zdu9g2Hn0Co7DFgxhoVz_Flh4qqmL6UXKSVTJ_DdJMBZEEmJaEX8281YJm7shDx2Uz_xY0cF6MSdBJlPFDl431ts26eoqMK2Px70ByfrPQxi8prDho6FkeCoTNlpOkGjQNcRkPiXZBHoQK2LTbd4hetelWxuFDbVzrB3l90pWSy0DezusS2VVdluO8MI_nwJddC6Ur1gX2U7X8rt-yqrD0yh7OU-DC_zvop9PWJdQnu5y_51crp1Pp9RPpd1gr5R0qIG9HR7IEAzraZ0wOF156TH3wACRJ6hfSrOYZxBWS22AFpmBmnaAMOiUJCU1UZxQAJUqxkP_pBuFSYknyregVG4QJ4B1frEp5wZGTGO1SmdMKQmf2DymuGrzrWBIf6NQCmNOaTIByIZ_7zPTm8EDA9YJcsz9YiB3QxTBCtB1nXjxKOVNpenfqyQ4do8qjG-etsiLmuxU0uQidCaACcQBiECESI0QsRFjb1dj5maSiTXXr23ApEorVIhLudQjb1Yn0Z7QptEMlP5gq5pBZx7ocdr7KHB3PrrHI9qDzl4JthA4_oCqlW-eSYb_9A1y7luNRD6NVY3wN0Y0x1_a4t8diYm44XgIUdW-vj6B3jOdnD6i89H_eMn7LaNzNPIqfZYZT5bqKfIFOfRs3JKAvt-01bgP_R-f24 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Corticotropin-Releasing+Factor+receptor+1+%28CRF1%29+antagonism+in+patients+with+alcohol+use+disorder+and+high+anxiety+levels%3A+effect+on+neural+response+during+Trier+Social+Stress+Test+video+feedback&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Lee%2C+Mary+R.&rft.au=Rio%2C+Daniel&rft.au=Kwako%2C+Laura&rft.au=George%2C+David+T.&rft.date=2023-04-01&rft.pub=Springer+International+Publishing&rft.issn=0893-133X&rft.eissn=1740-634X&rft.volume=48&rft.issue=5&rft.spage=816&rft.epage=820&rft_id=info:doi/10.1038%2Fs41386-022-01521-z&rft_id=info%3Apmid%2F36564531&rft.externalDocID=PMC10066297 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon |